Hypothalamic neurogenesis and its implications for obesity-induced anxiety disorders

被引:5
|
作者
Samodien, Ebrahim [1 ]
Chellan, Nireshni [1 ,2 ]
机构
[1] South African Med Res Council, Biomed Res & Innovat Platform, ZA-7503 Cape Town, South Africa
[2] Stellenbosch Univ, Dept Med Physiol, Cape Town, South Africa
基金
英国医学研究理事会;
关键词
Anxiety; Depression; Exercise; Hippocampus; Hypothalamus; Nutraceuticals; Neurogenesis; Obesity; HIGH-FAT-DIET; NEUROTROPHIC FACTOR; HIPPOCAMPAL NEUROGENESIS; VENTROMEDIAL NUCLEUS; CELL-PROLIFERATION; STEM-CELLS; ADULT; TANYCYTES; NEURONS; MOUSE;
D O I
10.1016/j.yfrne.2020.100871
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Obesity and anxiety are public health problems that have no effective cure. Obesity-induced anxiety is also the most common behavioural trait exhibited amongst obese patients, with the mechanisms linking these disorders being poorly understood. The hypothalamus and hippocampus are reciprocally connected, important neurogenic brain regions that could be vital to understanding these disorders. Dietary, physical activity and lifestyle interventions have been shown to be able to enhance neurogenesis within the hippocampus, while the effects thereof within the hypothalamus is yet to be ascertained. This review describes hypothalamic neurogenesis, its impairment in obesity as well as the effect of interventional therapies. Obesity is characterized by a neurogenic shift towards neuropeptide Y neurons, promoting appetite and weight gain. While, nutraceuticals and exercise promote proopiomelanocortin neuron proliferation, causing diminished appetite and reduced weight gain. Through the furthered development of multimodal approaches targeting both these brain regions could hold an even greater therapeutic potential.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Adipocytes modulate the electrophysiology of atrial myocytes: implications in obesity-induced atrial fibrillation
    Yung-Kuo Lin
    Yao-Chang Chen
    Jenn-Han Chen
    Shih-Ann Chen
    Yi-Jen Chen
    Basic Research in Cardiology, 2012, 107
  • [42] Control of tuberal hypothalamic development and its implications in metabolic disorders
    Placzek, Marysia
    Chinnaiya, Kavitha
    Kim, Dong Won
    Blackshaw, Seth
    NATURE REVIEWS ENDOCRINOLOGY, 2025, 21 (02) : 118 - 130
  • [43] Adipocytes modulate the electrophysiology of atrial myocytes: implications in obesity-induced atrial fibrillation
    Lin, Yung-Kuo
    Chen, Yao-Chang
    Chen, Jenn-Han
    Chen, Shih-Ann
    Chen, Yi-Jen
    BASIC RESEARCH IN CARDIOLOGY, 2012, 107 (05)
  • [44] Obesity-Induced Lymphatic Valve Dysfunction
    Castorena-Gonzalez, Jorge A.
    Jablon, Kelli L.
    Akerstrom, Victoria L.
    FASEB JOURNAL, 2022, 36
  • [45] Obesity-Induced Hypertension: New Insights
    Antza, Christina
    Stabouli, Stella
    Natsis, Michalis
    Doundoulakis, Ioannis
    Kotsis, Vasilios
    CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (31) : 4620 - 4625
  • [46] Obesity-induced Upper Extremity Lymphedema
    Greene, Arin K.
    Maclellan, Reid A.
    PLASTIC AND RECONSTRUCTIVE SURGERY-GLOBAL OPEN, 2013, 1 (07)
  • [47] CARDIOVASCULAR REGULATION IN OBESITY-INDUCED HYPERTENSION
    ROCCHINI, AP
    HYPERTENSION, 1992, 19 (01) : I56 - I60
  • [48] METHOTREXATE: AN OPTION FOR OBESITY-INDUCED ASTHMA?
    Knight, Seth
    Khosravi, Mehdi
    CHEST, 2021, 160 (04) : 1765A - 1765A
  • [49] OBESITY-INDUCED HYPERPLASTIC LUNG GROWTH
    INSELMAN, LS
    WAPNIR, RA
    SPENCER, H
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1987, 135 (03): : 613 - 616
  • [50] RENAL PATHOPHYSIOLOGY IN OBESITY-INDUCED HYPERTENSION
    HALL, JE
    HERRERA, GA
    GRANGER, JP
    HYPERTENSION, 1991, 18 (03) : 395 - 395